Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
Organization not stated
Board Member
Proxy statement
2015-01-01–present
2014-01-01–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Board Member
2014-01-01–present
Company
Board Member
2015-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Atea Pharmaceuticals, Inc. (AVIR) | President, Chief Executive Officer and Chairman of the Board | $703,490 | $3,403,752 |
| 2024 | Atea Pharmaceuticals, Inc. (AVIR) | President, Chief Executive Officer and Chairman of the Board | $703,490 | $4,202,323 |
| 2023 | Atea Pharmaceuticals, Inc. (AVIR) | President, Chief Executive Officer and Chairman of the Board | $683,000 | $5,925,790 |
| 2022 | Atea Pharmaceuticals, Inc. (AVIR) | President, Chief Executive Officer and Chairman of the Board | $650,000 | $5,878,026 |
| 2021 | Atea Pharmaceuticals, Inc. (AVIR) | President, Chief Executive Officer and Chairman of the Board | $650,000 | $34,104,892 |
| 2020 | Atea Pharmaceuticals, Inc. (AVIR) | President, Chief Executive Officer and Chairman of the Board | $436,862 | $2,886,987 |
| 2019 | Atea Pharmaceuticals, Inc. (AVIR) | President, Chief Executive Officer and Chairman of the Board | $400,000 | $811,080 |
Earnings-call appearances and filed executive appointments or departures, newest first.
